News | October 22, 2014

First Texas Hospital to Implant Solo Smart Aortic Pericardial Heart Valve

Heart Hospital of Austin implants the Solo Smart Heart Valve

Oct. 22, 2014 — Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J. Dewan M.D., performed the procedure at Heart Hospital of Austin.

The Solo Smart valve is the first valve with a removable stent to be approved in the U.S. market. Designed from bovine pericardium, the valve is fully biological, with no synthetic material added. This prosthesis mimics the healthy native aortic valve, preserves the aortic root physiology, eliminates excess synthetic material and maximizes blood flow.

The Solo Smart valve also features a removable nickel-titanium alloy stent, which provides support during implantation, but it is completely removed once the valve is sutured in. Once the stent is removed following implantation, the Solo Smart valve becomes an entirely stentless valve, providing low pressure gradients and large openings.

The Solo Smart Aortic Pericardial Heart Valve was approved by the U.S. Food and Drug Administration (FDA) in July 2014. Cardiothoracic and Vascular Surgeons will be training surgeons on how to implant the new valve at Heart Hospital of Austin, which is one of four current training sites across the United States.

Related Content

Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation
Feature | Heart Valve Technology | December 12, 2018
A jury in the U.S. District Court for the District of Delaware determined Dec. 11 that the Boston Scientific U.S....
First TriCinch Coil Tricuspid Repair Systems Implanted in U.S.
News | Heart Valve Technology | November 06, 2018
4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug...
Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018
Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally...
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Overlay Init